Web Results



Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the ...

Tasigna - Home


... of Product Characteristics; Print. TASIGNA (nilotinib) .... TASIGNA<sup>®</sup> (Nilotinib) is approved for use in 110 countries around the world. Healthcare Professionals  ...

Nilotinib | C28H22F3N7O - PubChem


Nilotinib | C28H22F3N7O | CID 644241 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, ...

Should Patients and Families Be Considering Tasigna (Nilotinib ...


Oct 21, 2015 ... The NPF Recommends Further Study but Not Clinical Use of this Investigational Drug. Tasigna (Nilotinib) is a leukemia drug that has recently ...

Tasigna - Novartis


See full prescribing information for. TASIGNA. TASIGNA® (nilotinib) Capsules for oral use. Initial U.S. Approval: 2007. WARNING: QT PROLONGATION AND ...

Tasigna Capsules (Nilotinib Capsules): Side Effects, Interactions ...


Nov 30, 2015 ... Learn about Tasigna Capsules (Nilotinib Capsules) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, ...

Nilotinib (Tasigna) | Cancer Research UK


Jan 2, 2015 ... Read about the cancer treatment drug nilotinib, otherwise known as Tasigna, including what it is, how it works and possible side effects.

Nilotinib - Chemotherapy Drugs - Chemocare


(nye-LOE-ti-nib). Generic Name: nilotinib. Trade Name(s): Tasigna. Nilotinib is the generic for the trade chemotherapy drug Tasigna. In some cases, health care  ...

Nilotinib: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for nilotinib. Includes indications, proper use, special instructions, precautions, and possible side effects.

Nilotinib Drug Interactions - Drugs.com


933 medications are known to interact with nilotinib. Includes Bayer Aspirin with Heart Advantage (aspirin), Clexane (enoxaparin), Coumadin (warfarin).

More Info

Nilotinib: MedlinePlus Drug Information


Nilotinib may cause QT prolongation (an irregular heart rhythm that can lead to fainting, loss of consciousness, seizures, or sudden death). Tell your doctor if you  ...

FDA Approval for Nilotinib - National Cancer Institute


Jul 3, 2013 ... Information from the FDA about the approval of nilotinib and the clinical trials that led to the approval.

DrugBank: Nilotinib


Nilotinib, also known as AMN107, is a tyrosine kinase inhibitor under investigation as a possible treatment for chronic myelogenous leukemia (CML). In June ...